AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2025
Aug 20, 2025
31676_dirs_2025-08-20_33badb3c-2fe7-448c-8b92-8c11ea601823.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2025-08-18
Reporting Person: Thoma Jeanne (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-18 | Common Stock | S | 6865 | $89.76 | Disposed | 38080 | Direct |
| 2025-08-18 | Common Stock | S | 14675 | $88.87 | Disposed | 23405 | Direct |
Footnotes
F1: The shares were sold in multiple trades at prices ranging from $89.75 to $89.90. The price reported above reflects the weighted average sales price.
F2: The shares were sold in multiple trades at prices ranging from $88.74 to $89.39. The price reported above reflects the weighted average sales price.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3